Determinants of renal flow reserve in adult patients with and without renal artery stenosis
Physiological Reports · 2025
DOI: 10.14814/phy2.70572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von T A Bouwmeester und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Renal Artery Obstruction, Renal Circulation, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nierstichting (Dutch Kidney Foundation), AUMC | Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers (ACS), Amsterdam University Medical Centers (AUMC).
Abstract (Originalsprache)
Renal flow reserve (RFR) is a hemodynamic measure of renal microvascular function and may help identify patients with renal artery stenosis (RAS) who could benefit from revascularization. Reference ranges and clinical correlates of RFR in patients with and without RAS remain unknown. We analyzed intra‐arterial renal flow velocity measurements from 76 participants with and without RAS, all with eGFR ≥30 mL/min/1.73m 2 . Each underwent baseline and dopamine‐induced hyperemic flow assessments using an intrarenal bolus of 30 μg/kg. RFR was defined as the ratio of mean hyperemic to baseline flow. Group differences were assessed using descriptive statistics and linear regression models adjusting for potential confounders. Median RFR was similar between participants with RAS (1.73, IQR 1.31–2.11) and those without (1.88, IQR 1.60–2.47). Lower RFR was associated with lower eGFR ( p = 0.027). Higher RFR values were observed in participants using beta‐blockers ( p = 0.010), independent of age, sex, eGFR, and blood pressure. RFR was negatively associated with eGFR and positively with beta‐blocker use. No associations were found with age, sex, hypertension, diabetes, or presence of RAS. The link with beta‐blockers may be caused by interactions with the systemic and renal dopaminergic system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department Interventional Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department Interventional Radiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department Internal Medicine, Section Nephrology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Sciences, Amsterdam UMC, Amsterdam, The Netherlands.
ORCID-Profile: T A Bouwmeester
Förderung
- Nierstichting (Dutch Kidney Foundation)
- AUMC | Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers (ACS)
- Amsterdam University Medical Centers (AUMC)
- Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers
Zitieren
APA
Bouwmeester, T. A., van de Velde, L., Collard, D., Delewi, R., Lamers, A. B. G. N., Beijk, M. A. M., de Winter, R. J., Zijlstra, I. A. J., Vogt, L., & van den Born, B. J. H. (2025). Determinants of renal flow reserve in adult patients with and without renal artery stenosis. Physiological Reports. https://doi.org/10.14814/phy2.70572
Vancouver
Bouwmeester TA, van de Velde L, Collard D, Delewi R, Lamers ABGN, Beijk MAM, et al. Determinants of renal flow reserve in adult patients with and without renal artery stenosis. Physiological Reports. 2025. doi:10.14814/phy2.70572
BibTeX
@article{Bouwmeester2025,
author = {Bouwmeester, T A and van de Velde, L and Collard, D and Delewi, R and Lamers, A B G N and Beijk, M A M and de Winter, R J and Zijlstra, I A J and Vogt, L and van den Born, B J H},
title = {Determinants of renal flow reserve in adult patients with and without renal artery stenosis},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70572}
}
EUVIMED